‘Ηαρ
oΎΊδBEopπ{s΅½ΰpγΗ§«δB]ΪΜ1α
σ©@hκ1, gc@°1, ½ϋ@Φj1, qμ@_i1, δ@Νl2, ΰc@pρ3
1ϊ{γΘεw½iRa@OΘ
2ϊ{γΘεw½iRa@YwlΘ
3ϊ{γΘεwΑ»νOΘ
Solitary Splenic Metastasis from Ovarian Cancer Managed by Laparoscopic Splenectomy
Keiichi Asami1, Hiroshi Yoshida1, Atsushi Hirakata1, Hiroshi Makino1, Akihito Nakai2 and Eiji Uchida3
1)Department of Surgery, Nippon Medical School Tama Nagayama Hospital
2)Department of Gynecology, Nippon Medical School Tama Nagayama Hospital
3)Department of Gastrointestinal Surgery, Nippon Medical School

A 67-year old woman underwent bilateral oophorectomy for the treatment of ovarian cancer (serous adenocarcinoma, pT3cN0M0 Stage IIIc) in 2012, and postoperative chemotherapy was started. Ten months after operation, the serum level of CA125 was elevated (57.6 U/mL). Eighteen months after operation, an abdominal CT scan showed a mass in the spleen, 15 mm in diameter. Twenty three months after operation, splenic mass had increased to 24 mm in diameter. We diagnosed solitary splenic metastasis from ovarian cancer, and performed laparoscopic splenectomy. The pathological diagnosis of the splenic tumor was serous adenocarcinoma compatible with metastasis from ovarian cancer. She was discharged on 5th postoperative days and underwent another adjuvant chemotherapy. Since solitary splenic metastasis from ovarian cancer is rare. The laparoscopic splenectomy is a safe and effective for the management of splenic tumors.
ϊγεγο 2015; 11(1), 25-28
Key words
ovarian cancer, splenic metastasis, laparoscopic splenectomy
Correspondence to
Hiroshi Yoshida, Department of Surgery, Nippon Medical School Tama Nagayama Hospital, 1-7-1 Nagayama, Tama Tokyo 206-8512, Japan
E-mailFhiroshiy@nms.ac.jp
σtF2014N95ϊ@σF2014N1015ϊ |